Gene therapy for catecholaminergic polymorphic ventricular tachycardia by inhibition of Ca(2+)/calmodulin-dependent kinase II

BACKGROUND: Catecholaminergic polymorphic ventricular tachycardia (CPVT), an inherited cardiac arrhythmia characterized by adrenergically triggered arrhythmias, is inadequately treated by current standard of care. Ca(2+)/calmodulin-dependent protein kinase II (CaMKII), an adrenergically activated ki...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Circulation
Main Authors: Bezzerides, Vassilios J., Caballero, Ana, Wang, Suya, Ai, Yulan, Hylind, Robyn J., Lu, Fujian, Heims-Waldron, Danielle A., Chambers, Kristina D., Zhang, Donghui, Abrams, Dominic J., Pu, William T.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7274838/
https://ncbi.nlm.nih.gov/pubmed/31155924
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.118.038514
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados